Short-term outcomes of greenlight HPS™ laser photoselective vaporization prostatectomy (PVP) for benign prostatic hyperplasia (BPH)

Massimiliano Spaliviero, Motoo Araki, Carson Wong

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Purpose: We evaluated our initial experience with the GreenLight HPS™ laser, a technologically improved version of the potassium-titanyl-phosphate (KTP) laser for PVP. Materials and Methods: Transurethral PVP was performed using a GreenLight HPS™ side-firing laser system. Patients had American Urological Association Symptom Score (AUASS), Quality of Life (QoL) score, Sexual Health Inventory for Men (SHIM) score, serum prostate specific antigen (PSA), maximum flow rate (Qmax) and post void residual (PVR) determinations and volumetric prostate measurements with transrectal ultrasonography (TRUS). Laser and operative times and energy usage were recorded. AUASS, QoL, SHIM, Qmax and PVR were evaluated 1, 4, 12, 24, and 52 weeks post-surgery. Serum PSA and TRUS were obtained at 12 weeks and serum PSA was repeated at 52 weeks. Results: Seventy consecutive patients with a median age of 67 (45-86) years underwent GreenLight HPS™ laser PVP from July 2006 through March 2008. Median prostate volume was 61.6 (20.9-263.0) mL with a median PSA of 1.4 (0.1 -10.1) ng/mL. Mean laser and operative times and energy usage were 13 (3-34) minutes, 30 (6-100) minutes and 85 (11-235) kJ, respectively. All were outpatient procedures with 49 (70%) patients catheter-free at discharge. No urethral strictures or urinary incontinence were noted. Median AUASS decreased from 22 to 8, 6, 5, 5, and 4 (p

Original languageEnglish
Pages (from-to)2341-2347
Number of pages7
JournalJournal of Endourology
Volume22
Issue number10
DOIs
Publication statusPublished - Oct 1 2008
Externally publishedYes

Fingerprint

Prostatic Hyperplasia
Laser Therapy
Prostate-Specific Antigen
Prostatectomy
Lasers
Reproductive Health
Solid-State Lasers
Operative Time
Prostate
Ultrasonography
Serum
Quality of Life
Urethral Stricture
Equipment and Supplies
Volatilization
Urinary Incontinence
Outpatients
Catheters

ASJC Scopus subject areas

  • Urology

Cite this

Short-term outcomes of greenlight HPS™ laser photoselective vaporization prostatectomy (PVP) for benign prostatic hyperplasia (BPH). / Spaliviero, Massimiliano; Araki, Motoo; Wong, Carson.

In: Journal of Endourology, Vol. 22, No. 10, 01.10.2008, p. 2341-2347.

Research output: Contribution to journalArticle

@article{ac02941ef40c45c48afc6979cb9f3180,
title = "Short-term outcomes of greenlight HPS™ laser photoselective vaporization prostatectomy (PVP) for benign prostatic hyperplasia (BPH)",
abstract = "Purpose: We evaluated our initial experience with the GreenLight HPS™ laser, a technologically improved version of the potassium-titanyl-phosphate (KTP) laser for PVP. Materials and Methods: Transurethral PVP was performed using a GreenLight HPS™ side-firing laser system. Patients had American Urological Association Symptom Score (AUASS), Quality of Life (QoL) score, Sexual Health Inventory for Men (SHIM) score, serum prostate specific antigen (PSA), maximum flow rate (Qmax) and post void residual (PVR) determinations and volumetric prostate measurements with transrectal ultrasonography (TRUS). Laser and operative times and energy usage were recorded. AUASS, QoL, SHIM, Qmax and PVR were evaluated 1, 4, 12, 24, and 52 weeks post-surgery. Serum PSA and TRUS were obtained at 12 weeks and serum PSA was repeated at 52 weeks. Results: Seventy consecutive patients with a median age of 67 (45-86) years underwent GreenLight HPS™ laser PVP from July 2006 through March 2008. Median prostate volume was 61.6 (20.9-263.0) mL with a median PSA of 1.4 (0.1 -10.1) ng/mL. Mean laser and operative times and energy usage were 13 (3-34) minutes, 30 (6-100) minutes and 85 (11-235) kJ, respectively. All were outpatient procedures with 49 (70{\%}) patients catheter-free at discharge. No urethral strictures or urinary incontinence were noted. Median AUASS decreased from 22 to 8, 6, 5, 5, and 4 (p",
author = "Massimiliano Spaliviero and Motoo Araki and Carson Wong",
year = "2008",
month = "10",
day = "1",
doi = "10.1089/end.2008.9708",
language = "English",
volume = "22",
pages = "2341--2347",
journal = "Journal of Endourology",
issn = "0892-7790",
publisher = "Mary Ann Liebert Inc.",
number = "10",

}

TY - JOUR

T1 - Short-term outcomes of greenlight HPS™ laser photoselective vaporization prostatectomy (PVP) for benign prostatic hyperplasia (BPH)

AU - Spaliviero, Massimiliano

AU - Araki, Motoo

AU - Wong, Carson

PY - 2008/10/1

Y1 - 2008/10/1

N2 - Purpose: We evaluated our initial experience with the GreenLight HPS™ laser, a technologically improved version of the potassium-titanyl-phosphate (KTP) laser for PVP. Materials and Methods: Transurethral PVP was performed using a GreenLight HPS™ side-firing laser system. Patients had American Urological Association Symptom Score (AUASS), Quality of Life (QoL) score, Sexual Health Inventory for Men (SHIM) score, serum prostate specific antigen (PSA), maximum flow rate (Qmax) and post void residual (PVR) determinations and volumetric prostate measurements with transrectal ultrasonography (TRUS). Laser and operative times and energy usage were recorded. AUASS, QoL, SHIM, Qmax and PVR were evaluated 1, 4, 12, 24, and 52 weeks post-surgery. Serum PSA and TRUS were obtained at 12 weeks and serum PSA was repeated at 52 weeks. Results: Seventy consecutive patients with a median age of 67 (45-86) years underwent GreenLight HPS™ laser PVP from July 2006 through March 2008. Median prostate volume was 61.6 (20.9-263.0) mL with a median PSA of 1.4 (0.1 -10.1) ng/mL. Mean laser and operative times and energy usage were 13 (3-34) minutes, 30 (6-100) minutes and 85 (11-235) kJ, respectively. All were outpatient procedures with 49 (70%) patients catheter-free at discharge. No urethral strictures or urinary incontinence were noted. Median AUASS decreased from 22 to 8, 6, 5, 5, and 4 (p

AB - Purpose: We evaluated our initial experience with the GreenLight HPS™ laser, a technologically improved version of the potassium-titanyl-phosphate (KTP) laser for PVP. Materials and Methods: Transurethral PVP was performed using a GreenLight HPS™ side-firing laser system. Patients had American Urological Association Symptom Score (AUASS), Quality of Life (QoL) score, Sexual Health Inventory for Men (SHIM) score, serum prostate specific antigen (PSA), maximum flow rate (Qmax) and post void residual (PVR) determinations and volumetric prostate measurements with transrectal ultrasonography (TRUS). Laser and operative times and energy usage were recorded. AUASS, QoL, SHIM, Qmax and PVR were evaluated 1, 4, 12, 24, and 52 weeks post-surgery. Serum PSA and TRUS were obtained at 12 weeks and serum PSA was repeated at 52 weeks. Results: Seventy consecutive patients with a median age of 67 (45-86) years underwent GreenLight HPS™ laser PVP from July 2006 through March 2008. Median prostate volume was 61.6 (20.9-263.0) mL with a median PSA of 1.4 (0.1 -10.1) ng/mL. Mean laser and operative times and energy usage were 13 (3-34) minutes, 30 (6-100) minutes and 85 (11-235) kJ, respectively. All were outpatient procedures with 49 (70%) patients catheter-free at discharge. No urethral strictures or urinary incontinence were noted. Median AUASS decreased from 22 to 8, 6, 5, 5, and 4 (p

UR - http://www.scopus.com/inward/record.url?scp=54249130304&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=54249130304&partnerID=8YFLogxK

U2 - 10.1089/end.2008.9708

DO - 10.1089/end.2008.9708

M3 - Article

VL - 22

SP - 2341

EP - 2347

JO - Journal of Endourology

JF - Journal of Endourology

SN - 0892-7790

IS - 10

ER -